10/11/2026
FDA seeks public input on ibogaine trial safety
Ibogaine trials for opioid use disorder face scrutiny over safety.
Topic archive
washington, d.c.
5 stories
8/26/2026
University of Miami gifts 1994 ibogaine IND to HHS
The move promotes open science and could influence future psychedelic research.
8/10/2026
Ibogaine trials for opioid use disorder get ARPA-H boost
ARPA-H seeks to accelerate ibogaine trials for opioid treatment
8/7/2026
Psyence Biomedical unveils strategic plans in new investor presentation
Psyence Biomedical outlines its focus on psychedelic therapeutics for mental health in a recent investor update.
7/31/2026
Congressman Luttrell champions ibogaine for PTSD treatment
Luttrell's IBOGAINE Act aims to solidify psychedelic therapy access for veterans.